Title: Suzanne E. Mckenna: Innovator in Neuroprotection and Therapeutics
Introduction
Suzanne E. Mckenna is a notable inventor based in the United States, recognized for her contributions to the field of neuroprotection and therapeutic methods. Her work primarily focuses on developing novel ApoE peptide derivatives that have significant implications for treating various disorders.
Latest Patents
Suzanne holds a patent titled "Improved Apo E Analogs And Methods For Their Use." This invention discloses novel ApoE peptide derivatives and ApoE-protein transduction domain conjugates. These innovations are useful for treating disorders such as CNS inflammation, traumatic brain injury, inflammatory bowel disease, cerebral ischemia, atherosclerosis, sepsis, multiple sclerosis, arthritic diseases, Alzheimer's Disease, and other brain disorders. The invention also encompasses methods for protecting subjects who have undergone irradiation or radiotherapy through the administration of ApoE or at least one ApoE mimetic peptide.
Career Highlights
Suzanne is currently associated with Cognosci, Incorporated, where she continues to advance her research and development efforts. Her work has the potential to significantly impact the treatment of various neurological and inflammatory conditions.
Collaborations
Some of her notable coworkers include Michael P. Vitek and Christopher R. Self, who contribute to her research endeavors and collaborative projects.
Conclusion
Suzanne E. Mckenna's innovative work in developing ApoE peptide derivatives showcases her commitment to advancing therapeutic methods for critical health issues. Her contributions are paving the way for new treatments in neuroprotection and inflammation management.